selective androgen receptor modulator LY2452473
Term · Oncology and biomedicine · MLC-T-ONC-016664
An orally bioavailable selective androgen receptor modulator (SARM), with potential tissue-selective androgenic/anti-androgenic activity. Upon oral administration, LY2452473 acts as an agonist in select tissues and organs, including skeletal muscle, bone and the penis, thereby binding to and activating androgen receptor (AR) while acting as an antagonist in the prostate, thereby blocking AR activation and AR-mediated cellular proliferation. This may improve muscle mass and strength, bone formation, and erectile dysfunction while not stimulating growth of the prostate.
| Identifier | MLC-T-ONC-016664 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | SARM LY2452473; LY SARM |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016664",
"term": "selective androgen receptor modulator LY2452473",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable selective androgen receptor modulator (SARM), with potential tissue-selective androgenic/anti-androgenic activity. Upon oral administration, LY2452473 acts as an agonist in select tissues and organs, including skeletal muscle, bone and the penis, thereby binding to and activating androgen receptor (AR) while acting as an antagonist in the prostate, thereby blocking AR activation and AR-mediated cellular proliferation. This may improve muscle mass and strength, bone formation, and erectile dysfunction while not stimulating growth of the prostate.",
"synonyms": [
"SARM LY2452473",
"LY SARM"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/selective-androgen-receptor-modulator-ly2452473/"
}
Record 14,795 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.